Therapy of gastric mucosa-associated lymphoid tissue lymphoma (Q36847291)

16 August 2017

1 reference

title

Therapy of gastric mucosa-associated lymphoid tissue lymphoma (English)

1 reference

16 August 2017

Stefan Wöhrer

1

1 reference

16 August 2017

Marlene Troch

series ordinal

2

1 reference

16 August 2017

Markus Raderer

series ordinal

3

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

Expert Opinion on Pharmacotherapy

16 August 2017

1 reference

16 August 2017

8

1 reference

16 August 2017

9

1 reference

16 August 2017

1263-1273

1 reference

The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.

16 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Regional specialization in the mucosal immune system: primed cells do not always home along the same track

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Chemotherapy in gastric cancer: a review and updated meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Human Peyer's patches: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Delving deeper into MALT lymphoma biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Paris staging system for primary gastrointestinal lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Gastric MALT lymphoma: from aetiology to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Reverse transcription-PCR for t(11;18)(q21;q21) staging and monitoring in mucosa-associated lymphoid tissue lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Cholecystectomy and bowel function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Effective regimens for the treatment of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Interobserver variation in the histopathological assessment of malt/malt lymphoma: towards a consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

High relapse rate in patients with MALT lymphoma warrants lifelong follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Gastric MALT lymphoma: from concept to cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Treatment results of primary stage I and II non-Hodgkin's lymphoma of the stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Low-grade MALT lymphoma of the stomach: a review of treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Primary gastric malignant lymphoma followed by gastric adenocarcinoma.Report of 4 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Gastric adenocarcinoma after gastric lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Lymphoma of the stomach following gastric surgery for benign peptic ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Lymphocytic gastritis, gastric adenocarcinoma, and primary gastric lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1263

10.1517/14656566.8.9.1263

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference